Medicalook
Medicalook

Derfon

http://www.medicalook.com
Derfon

Derfon review





Derfon is a sympathomimetic stimulant that is marketed as an appetite suppressant. It is known as Tenuate and Tenuate Dospan, is similar to amphetamine, and is an anorectic or anorexigenic medicament.

Derfon is a chemical analog to a similar antidepressant, which is effective as medicament to stop smoking. Derfon stimulates the central nervous system and may increase the heart rate and blood pressure while decreasing appetite.

Marketed as an appetite suppressant, this controlled substance is used to treat obesity, diet, and to counter depression. Derfon is listed by the FDA in pregnancy category B meaning it is found to not cause harm to an unborn fetus. Expecting mothers should not take this medicament without consulting their physician first.

Derfon is a controlled substance Schedule IV and can be obtained only with a prescription. It is available in 25 mg tablets and 75mg control-released tablets by the names Tenuate, Ten-Tab and Teparil.

Common side effects include wamble, headaches, bouts of insomnia, psychosis, and the more serious side effects such as pulmonary hypertension, and ultimately a stroke.

Less common side effects include xerostalmia, or a metallic taste in foods, blurred vision or photosensitivity, allergies and rashes. More serious side effects include a decrease in the patient’s libido (sexual activity) and can lead to eventual erectile dysfunction. Some neurological and psychological side effects include depression, anxiety, drilling headaches, restlessness, tremors, dizziness and seizures.

Caution is necessary when taking Derfon, especially when performing activities like driving or machine operation. Derfon is a stimulant medicament, masking tiredness and causing languidness leading to problems in vision, speech and motion. Note that this medicament can be habit forming.

Patients with a history of heart illnesss or high blood pressure are not recommended to take Derfon, including patients diagnosed with arteriosclerosis or the stiffening of the arteries. Patients with glaucoma should not take this medicament.

Patients taking monoamine oxidase inhibitor medicaments (Monoamine oxidaseIs) within the last two weeks may not be able to take this medicament. Mixing Monoamine oxidaseIs with Derfon may have a lethal effect on the patient. Patients with a history of medicament and alcohol abuse are prohibited from taking the medicament. It is habit forming and these patients may have a hard time stopping the use of the medicament.

Derfon cannot be taken with other anorectic medicaments whether prescribed, over the counter or herbal. Pregnant women should only use this medicament when needed. Breastfeeding women need to weigh the benefits of taking the medicament against the potential risk it may bring to the nursing infant prior to taking the medicament.

Derfon has the following structural formula:

Chemical structure of Derfon


• Molecular formula of Derfon is C13H19NO
• Chemical IUPAC Name is 2-diethylamino-1-phenylpropan-1-one
• Molecular weight is 205.2961 g/mol
Derfon available : 25mg tablets and 75mg tablets

Generic name: Diethylpropion

Brand name(s): Adiposon, Amfepramon, Amfepramone, Amphepramon, Amphepramone, Anfamon, Anorex, Cegramine, Danylen, Dobesin, Frekentine, Keramik, Keramin, Magrene, Moderatan, Modulor, Neobes, Nopropiophenone, Obesitex, Parabolin, Prefamone, Regenon, Reginon, Silutin, Tenuate, Tepanil, Tylinal

  Your Derfon review